BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15887863)

  • 1. Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma.
    Isidro ML; Iglesias Díaz P; Matías-Guiu X; Cordido F
    J Endocrinol Invest; 2005 Feb; 28(2):162-5. PubMed ID: 15887863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegaly associated with gangliocytoma.
    Crowley RK; Al-Derazi Y; Lynch K; Rawluk D; Thompson CJ; Farrell M; Agha A
    Ir J Med Sci; 2012 Sep; 181(3):353-5. PubMed ID: 19789938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary gangliocytoma-adenoma presenting with acromegaly: response to treatment.
    Luna V; Morales F; Luengo LM; Sanz A; Diaz J
    Arch Intern Med; 2001 Apr; 161(7):1010-1. PubMed ID: 11295968
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
    Drange MR; Melmed S
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3104-9. PubMed ID: 9745411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined neuronal and endocrine tumors of the sellar region].
    Saeger W; Lüdecke DK; Losa M
    Pathologe; 1997 Nov; 18(6):419-24. PubMed ID: 9451729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrasellar gangliocytomas associated with acromegaly.
    Kurosaki M; Saeger W; Lüdecke DK
    Brain Tumor Pathol; 2002; 19(2):63-7. PubMed ID: 12622135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases.
    Saeger W; Puchner MJ; Lüdecke DK
    Virchows Arch; 1994; 425(1):93-9. PubMed ID: 7921420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma.
    Bevan JS; Asa SL; Rossi ML; Esiri MM; Adams CB; Burke CW
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):213-24. PubMed ID: 2512034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.
    Asa SL; Scheithauer BW; Bilbao JM; Horvath E; Ryan N; Kovacs K; Randall RV; Laws ER; Singer W; Linfoot JA
    J Clin Endocrinol Metab; 1984 May; 58(5):796-803. PubMed ID: 6423659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed gangliocytoma-pituitary adenoma containing GH and GHRH co-secreting adenoma cells.
    Teramoto S; Tange Y; Ishii H; Goto H; Ogino I; Arai H
    Endocrinol Diabetes Metab Case Rep; 2019 Oct; 2019():. PubMed ID: 31581122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid.
    Krassowski J; Zgliczyński W; Jeske W; Zgliczyński S
    J Clin Endocrinol Metab; 1999 May; 84(5):1761-2. PubMed ID: 10323416
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report.
    Morikawa M; Tamaki N; Kokunai T; Imai Y
    Neurosurgery; 1997 Mar; 40(3):611-4; discussion 614-5. PubMed ID: 9055303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed pituitary adenoma and gangliocytoma associated with acromegaly--case report.
    Asada H; Otani M; Furuhata S; Inoue H; Toya S; Ogawa Y
    Neurol Med Chir (Tokyo); 1990 Aug; 30(8):628-32. PubMed ID: 1703643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature.
    Ramírez C; Hernández-Ramirez LC; Espinosa-de-los-Monteros AL; Franco JM; Guinto G; Mercado M
    BMC Res Notes; 2013 Oct; 6():411. PubMed ID: 24119925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and biochemical spectrum of ectopic acromegaly.
    Fainstein-Day P; Ullmann TE; Dalurzo MCL; Sevlever GE; Smith DE
    Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101877. PubMed ID: 38413286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma.
    Vieira Neto L; Taboada GF; Corrêa LL; Polo J; Nascimento AF; Chimelli L; Rumilla K; Gadelha MR
    Endocr Pathol; 2007; 18(1):46-52. PubMed ID: 17652801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly.
    Amato G; Mazziotti G; Rotondi M; Iorio S; Doga M; Sorvillo F; Manganella G; Di Salle F; Giustina A; Carella C
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):65-71. PubMed ID: 11849248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.